These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38613943)

  • 1. Postvaccination serosurveillance of foot-and-mouth disease through virus-neutralizing and nonstructural protein antibody tests on pig farms in Taiwan: 2009-2020.
    Lee MC; Sun YF; Deng MC; Lin NN; Hsu JP; Chiou CJ; Tu WJ; Chen SP
    Prev Vet Med; 2024 Jun; 227():106197. PubMed ID: 38613943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge.
    Chen SP; Lee MC; Sun YF; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR; Ellis TM
    Vaccine; 2007 May; 25(22):4464-9. PubMed ID: 17445957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of non-structural protein ELISA kits in nationwide FMD surveillance in pigs to demonstrate virus circulation in Taiwan.
    Chen SP; Lee MC; Sun YF; Yang PC
    Vet Microbiol; 2011 Sep; 152(3-4):266-9. PubMed ID: 21641128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to foot-and-mouth disease virus in pig farms after the 1997 outbreak in Taiwan.
    Chen SP; Sun YF; Lee MC; Cheng IC; Yang PC; Huang TS; Jong MH; Robertson ID; Edwards JR; Ellis TM
    Vet Microbiol; 2008 Jan; 126(1-3):82-90. PubMed ID: 17716836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a multiplex Luminex assay for detecting swine antibodies to structural and nonstructural proteins of foot-and-mouth disease virus in Taiwan.
    Chen TH; Lee F; Lin YL; Pan CH; Shih CN; Tseng CH; Tsai HJ
    J Microbiol Immunol Infect; 2016 Apr; 49(2):196-207. PubMed ID: 25074628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of foot-and-mouth disease virus-infected from vaccinated pigs by enzyme-linked immunosorbent assay using nonstructural protein 3AB as the antigen and application to an eradication program.
    Chung WB; Sorensen KJ; Liao PC; Yang PC; Jong MH
    J Clin Microbiol; 2002 Aug; 40(8):2843-8. PubMed ID: 12149340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
    Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K
    Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cedivac-FMD can be used according to a marker vaccine principle.
    Chénard G; Selman P; Dekker A
    Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sensitivity and specificity in three commercial foot-and-mouth disease virus non-structural protein ELISA kits with swine sera in Taiwan.
    Chen SP; Ellis TM; Lee MC; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR
    Vet Microbiol; 2007 Jan; 119(2-4):164-72. PubMed ID: 17112687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against foot-and-mouth disease II: Regaining FMD-free status.
    Backer JA; Engel B; Dekker A; van Roermund HJ
    Prev Vet Med; 2012 Nov; 107(1-2):41-50. PubMed ID: 22726463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of FMD virus non-structural protein antibodies in pig populations involved in an eradication programme.
    Chung WB; Liao PC; Yang PC; Chen SP; Jong MH; Sheu TW
    Vet Rec; 2003 May; 152(19):595-7. PubMed ID: 12762489
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological responses after vaccination of growing pigs with foot-and-mouth disease trivalent (type O, A and Asia1) vaccine.
    Lee HS; Lee NH; Seo MG; Ko YJ; Kim B; Lee JB; Kim JS; Park S; Shin YK
    Vet Microbiol; 2013 Jun; 164(3-4):239-45. PubMed ID: 23490554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Luminex assay for the detection of swine antibodies to non-structural proteins of foot-and-mouth disease virus.
    Chen TH; Lee F; Lin YL; Pan CH; Shih CN; Lee MC; Tsai HJ
    J Immunol Methods; 2013 Oct; 396(1-2):87-95. PubMed ID: 23962586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of Confirmatory Foot-and-Mouth Disease Virus Antibody ELISAs to Identify Infected Animals in Vaccinated Populations.
    Tewari A; Ambrose H; Parekh K; Inoue T; Guitian J; Nardo AD; Paton DJ; Parida S
    Viruses; 2021 May; 13(5):. PubMed ID: 34063385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
    Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
    Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vaccination on cattle subclinically infected with foot-and-mouth disease virus in Cameroon.
    Bertram MR; Delgado A; Pauszek SJ; Smoliga GR; Brito B; Stenfeldt C; Hartwig EJ; Jumbo SD; Abdoulmoumini M; Oliva Marie AA; Salhine R; Rodriguez LL; Garabed R; Arzt J
    Prev Vet Med; 2018 Jul; 155():1-10. PubMed ID: 29786519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against foot-and-mouth disease I: epidemiological consequences.
    Backer JA; Hagenaars TJ; Nodelijk G; van Roermund HJ
    Prev Vet Med; 2012 Nov; 107(1-2):27-40. PubMed ID: 22749763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-structural protein 3A for differentiation of foot-and-mouth disease infected and vaccinated animals in Haryana (India).
    Kumar N; Sharma R; Kakker NK
    Zoonoses Public Health; 2007; 54(9-10):376-82. PubMed ID: 18035976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved foot-and-mouth disease vaccine, O TWN-R, protects pigs against SEA topotype virus occurred in South Korea.
    Choi JH; Ko MK; Shin SH; You SH; Jo HE; Jo H; Lee MJ; Kim SM; Lee JS; Kim B; Park JH
    Vet Microbiol; 2019 Sep; 236():108374. PubMed ID: 31500734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.